FHIR-based healthcare interoperability platform for payers and value-based care
AaNeel builds standards-based data exchange software for health plans, ACOs and risk-bearing providers, plus a digital member health card. Its stack is firmly Microsoft-centric (.NET Core, C#, SQL Server, Cosmos DB, Azure DevOps) with Terraform and Kubernetes, and job posts point to an active migration of legacy systems onto Azure. Hiring is minimal and engineering-weighted, split between the US and India.
AaNeel is a privately held healthcare technology company founded in 2011 and headquartered in Tampa, Florida, with 51–200 employees. It sells to health plans, accountable care organizations and risk-bearing provider groups, connecting claims, clinical and longitudinal member data. The platform is HITRUST certified, FHIR-first and aligned with CMS interoperability and Blue Button 2.0 rules. AaNeel also offers the Health Access Card, a HIPAA-compliant digital member card giving authorized providers access to longitudinal records. Its solutions cover compliance readiness, care coordination, analytics and performance improvement.
AaNeel runs on .NET Core and C# with SQL Server and Azure Cosmos DB, React, Angular and TypeScript on the front end, and Azure, Kubernetes, Docker and Terraform for infrastructure, monitored with Datadog and Sumo Logic.
AaNeel is headquartered in Tampa, Florida, and hires in both the United States and India.
AaNeel is migrating legacy systems to Azure, automating cloud deployments, and supporting chronic care, transitional care and high-utilizer patient management programs.
Other companies in the same industry, closest in size
AaNeel's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.